Our Workshop Sessions
 
  
 
 1167: "Next-generation human risk assessment toward regulatory acceptance using read-across case studies” 
 
 
 
Tuesday, March 29, 2022, 3:50-4:10 p.m., Ballroom 6E
 
Presenting author: Sylvia Escher
 
 
 
2017: "Influence of extremely low-frequency magnetic fields on the development of childhood leukemia: An experimental study in a susceptible mouse model”
 
Monday, March 28, 2022, 4:00-4:15 p.m., CC Room 8
 
Presenting author: Dmitrij Sachno
 
 
 
Our Exhibitor-Hosted Sessions
 
 
 
Fraunhofer vs. Corona: Drug Repurposing Using the Example of Inhalation Therapy Against Covid-19
 
Monday, March 28, 2022, 9:00-10:00 a.m., CC Room 22
 
New drugs against Covid-19 are urgently needed. Repurposing of existing drugs enables faster development and minimizes risks. Inhalable drugs offer the benefits of non-invasive administration and less systemic side effects. Within the DRECOR project, we selected and identified drug repurposing candidates using in-vitro/in-vivo inhalation studies and PK/Tox assessments.
 
 
 
PBPK Modeling: The Road to Systemic Toxicity from External to Internal Exposure
 
Tuesday, March 29, 2022, 9:00-10:00 a.m., CC Room 22
 
Physiologically-based pharmacokinetic (PBPK) models intrinsically link external and internal exposure, dose response, and target organ toxicity. Integration of innovative in vitro test systems and knowledge on in vivo physiological parameters are crucial for an integrated approach to testing and assessment (IATA). Our PBPK model specifically addresses the complex dosimetry for inhalation toxicity.
 
 
 
 
Indoor Air Quality and Human Exposure
 
 
Wednesday, March 30, 2022, 9:00-10:00 a.m., CC Room 22
 
Nowadays, people spend most of their lives indoors – at work, home, schools, or traveling. Indoor air pollution has become an increasingly important issue, with one focus on ventilation and filter systems. Fraunhofer ITEM combines expertise in inhalation toxicology with chemical analyses and human exposure for selected scenarios.